Optimum Use Conditions; Contraindication; Warnings - Acelity PREVENA INCISION Manual De Uso

Ocultar thumbs Ver también para PREVENA INCISION:
Tabla de contenido

Publicidad

Idiomas disponibles

Idiomas disponibles

OPTIMUM USE CONDITIONS

For maximum benefit the PREVENA™ Therapy System should be applied immediately post
surgery to clean surgically closed wounds. It is to be continuously applied for a minimum of
two days up to a maximum of seven days. It can transition home with the patient.
The PREVENA™ Therapy System will not be effective in addressing complications associated
with the following:
ischemia to the incision or incision area
untreated or inadequately treated infection
inadequate hemostasis of the incision
cellulitis of the incision area
The PREVENA™ Therapy System should not be used to treat open or dehisced surgical wounds.
The V.A.C.® Therapy System should be considered for treatment of these wounds.
A V.A.C.® Therapy Unit with the smallest available canister should be considered for patients
who have exudate volumes that exceed the 45 ml PREVENA™ 125 Canister.
The PREVENA™ Therapy System should be used with caution in the following patients:
patients with fragile skin surrounding the incision as they may experience skin or tissue
damage upon removal of the PREVENA™ Dressing
patients who are at an increased risk of bleeding from the incision associated with the use
of anticoagulants and/or platelet aggregation inhibitors

CONTRAINDICATION

sensitivity to silver

WARNINGS

The PREVENA™ Therapy System is not intended to manage open or dehisced wounds.
DO NOT use with V.A.C. VERAFLO™ Therapy (Instillation) provided by the V.A.C.ULTA™
Therapy Unit. Instillation into the incision site may result in pooling of fluid which may result in
maceration.
Bleeding: Before applying the PREVENA™ Therapy System to patients who are at risk of
bleeding complications due to the operative procedure or concomitant therapies and/or
co-morbidities, ensure that hemostasis has been achieved and all tissue planes have been
approximated. If active bleeding develops suddenly or in large amounts during therapy, or
if frank blood is seen in the tubing or in the canister, the patient should leave the PREVENA™
Dressing in place, turn off the therapy unit and seek immediate emergency medical
assistance.
Infected Wounds: As with any wound treatment, clinicians and patients/caregivers should
frequently monitor the patient's wound, periwound tissue and exudate for signs of infection
or other complications. Some signs of infection are fever, tenderness, redness, swelling,
itching, rash, increased warmth in the wound or periwound area, purulent discharge or strong
odor. Infection can be serious, and can lead to complications such as pain, discomfort, fever,
gangrene, toxic shock, septic shock and/or fatal injury. Some signs or complications of systemic
infection are nausea, vomiting, diarrhea, headache, dizziness, fainting, sore throat with swelling
of the mucus membranes, disorientation, high fever, refractory and/or orthostatic hypotension
6

Publicidad

Capítulos

Tabla de contenido
loading

Este manual también es adecuado para:

Prevena customizable

Tabla de contenido